Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TCON | Tracon Pharmaceuticals, Inc. | PRESIDENT AND CEO, Director | $54.2K | Mar 12, 2024 | ||
FDMT | 4D Molecular Therapeutics, Inc. | Director | May 21, 2024 | |||
ONCT | Oncternal Therapeutics, Inc. | Director | Jun 20, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|